Charter Research, LLC

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease2 trials
• Down syndrome1 trial
• Frontotemporal dementia1 trial
• Mild cognitive impairment1 trial

Phase

• Phase 11 trial
• Phase 1/21 trial

Status

• Recruiting2 trials

Lead sponsor

• AC Immune SA1 trial
• Eli Lilly and Company1 trial

Running trials

• Recruiting

  A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

  NCT06297590· Phase 1· Eli Lilly and Company· Source

  Contact: Jeffrey Norton (principal investigator)

• Recruiting

  A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)

  NCT05462106· Phase 1/2· AC Immune SA· Source

  Contact: Olivier Sol, MD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease2 recruiting
• Down syndrome1 recruiting
• Frontotemporal dementia1 recruiting
• Mild cognitive impairment1 recruiting